Lumiata raises $10M to ramp up product development for population health risk assessment
Lumiata, a health IT company that enlists predictive analytics tool to zero in on individuals at risk for developing any of a handful of chronic conditions and projecting the trajectory of their risk over time, has raised a $10 million Series B round led by Intel Capital, according to a company statement.